tiprankstipranks
BioMark Diagnostics (DE:20B)
FRANKFURT:20B
Germany Market
20B
BioMark Diagnostics
RESEARCH TOOLSreports

BioMark Diagnostics (20B) Financial Statements

5 Followers

BioMark Diagnostics Financial Overview

BioMark Diagnostics's market cap is currently €33.03M. The company's EPS TTM is €-0.0141; its P/E ratio is -35.11; BioMark Diagnostics is scheduled to report earnings on July 29, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Jun 25Jun 24Jun 22Jun 21
Income Statement
Total RevenueC$ 59.79KC$ 154.22KC$ 163.22KC$ 153.49KC$ 0.00
Gross ProfitC$ -322.49KC$ 154.22KC$ 163.22KC$ -232.70KC$ -13.69K
Operating IncomeC$ -1.87MC$ -1.91MC$ -1.32MC$ -1.84MC$ -1.09M
EBITDAC$ -1.49MC$ -1.46MC$ -919.05KC$ -1.35MC$ -1.08M
Net IncomeC$ -1.48MC$ -1.93MC$ -1.43MC$ -1.84MC$ -1.09M
Balance Sheet
Cash & Short-Term InvestmentsC$ 1.01MC$ 2.48MC$ 156.75KC$ 72.04KC$ 877.68K
Total AssetsC$ 1.86MC$ 3.13MC$ 1.09MC$ 732.29KC$ 952.94K
Total DebtC$ 724.86KC$ 454.16KC$ 1.55MC$ 823.87KC$ 119.32K
Net DebtC$ 105.76KC$ -2.03MC$ 1.39MC$ 751.83KC$ -758.35K
Total LiabilitiesC$ 1.53MC$ 1.39MC$ 1.70MC$ 1.88MC$ 1.03M
Stockholders' EquityC$ 331.06KC$ 1.74MC$ -609.61KC$ -1.15MC$ -79.09K
Cash Flow
Free Cash FlowC$ -1.09MC$ -1.10MC$ -986.91KC$ -919.72KC$ -455.55K
Operating Cash FlowC$ -1.09MC$ -1.09MC$ -982.52KC$ -914.42KC$ -455.55K
Investing Cash FlowC$ -396.05KC$ -3.53KC$ -4.39KC$ -5.30KC$ -3.20K
Financing Cash FlowC$ -377.83KC$ 3.42MC$ 1.07MC$ 609.05KC$ 724.63K
Currency in CAD

BioMark Diagnostics Earnings and Revenue History

Income Statement >

BioMark Diagnostics Debt to Assets

Balance Sheet >

BioMark Diagnostics Cash Flow

Cash Flow >

BioMark Diagnostics Forecast EPS vs Actual EPS

Earnings >